Selank / Semax Blend
10mg + 10mg
$60.00
Selank / Semax Blend combines two synthetic neuropeptides in a single lyophilized vial. Selank is a heptapeptide derived from the immunomodulatory peptide tuftsin; Semax is derived from a fragment of adrenocorticotropic hormone (ACTH 4-10). Both appear in preclinical neuropeptide-signaling research.
For laboratory research use only.
SKU ASC-SS
Product detail
Description
Selank / Semax Blend combines two synthetic neuropeptides in a single lyophilized vial. Selank is a heptapeptide derived from the immunomodulatory peptide tuftsin; Semax is derived from a fragment of adrenocorticotropic hormone (ACTH 4-10). Both appear in preclinical neuropeptide-signaling research.
For laboratory research use only.
Documentation
The owner connected separate component-level reports for Selank 10mg and Semax 10mg to this single blend vial. These reports test the components separately and do not establish the identity, ratio, purity, sterility, or content of the finished blend vial.
Available reports for the whole catalog are published in the COA library.
Lot documentation
Each report below applies only to the sample, batch, and analyses named in that document. Reports are published as received. Where a report was supplied by the supplier rather than commissioned by ASCND Research, it is labelled as such.
Some of the reports below are component-level. Each of those covers a single component tested separately, not the finished vial as sold.
Selank + Semax 20mg — blend certificate of analysis
Supplier-supplied report. Not commissioned by ASCND Research.
- Laboratory
- pH Solutions
- Reference
- Lab ID 260807-02-ASC-10
- Batch
- XS20
- Reported purity
- 98%
- Reported content
- This report does not show a content result.
- Analyzed
- August 14, 2026
Scope of this report
Covers the finished blend vial: peptide purity by HPLC-UV at 220 nm and a microbial screen, both recorded as Pass. It reports Selank and Semax together as a single analyte, so it establishes the purity of the blend but NOT the ratio between the two peptides. The certificate spells the second peptide “SEEMAX”; it is reproduced here as printed. The certificate also carries a By Mass figure whose basis the laboratory has not confirmed, so no net content is stated.
Selank 10mg — component report
Supplier-supplied report. Not commissioned by ASCND Research.
- Laboratory
- Janoshik
- Reference
- Task 68847
- Batch
- SK11/2025-06
- Reported purity
- 99.875%
- Reported content
- 12.02mg
- Analyzed
- June 25, 2025
Scope of this report
Component-level report. Does not establish the identity, ratio, purity, sterility, or content of the finished blend vial.
Semax 10mg — component report
Supplier-supplied report. Not commissioned by ASCND Research.
- Laboratory
- Janoshik
- Reference
- Task 68846
- Batch
- XA11/2025-06
- Reported purity
- 99.499%
- Reported content
- 11.80mg
- Analyzed
- June 25, 2025
Scope of this report
Component-level report. The laboratory states the sample was filtered prior to analysis due to floating insoluble particles. Does not establish the identity, ratio, purity, sterility, or content of the finished blend vial.
Research-use notice
For laboratory and research use only. Not for human consumption, veterinary use, or medical application. Purchaser must be 21 years or older.